Optima Health - stronger-than-expected FY26 outcome17 Apr 2026 14:48
.wealthoracle.co.uk/featured-companies
Optima’s positive year-end update points to a stronger-than-expected FY26 outcome, with adjusted EBITDA now expected to be around 10% ahead of market expectations. Based on cited consensus of £18.1m, that implies a result close to £20m, which is a meaningful beat and suggests a stronger second half operational performance than the market had been anticipating. The upgrade matters for two reasons. First, it reinforces that Optima’s core business is executing well against plan. Management highlighted continued progress against its strategic objectives and medium-term targets of £200m revenue and £40m adjusted EBITDA, which indicates confidence not only in current trading but in the scalability of the platform. Second, the result appears to be supported by both underlying trading momentum and a one-off benefit from the procurement settlement, which added £2.3m in H1 and a further £2.4m in H2 as other operating income. That distinction is important. The settlement clearly boosts reported performance in FY26, so investors will need to separate this from the underlying earnings run-rate. Even so, the tone of the statement suggests the core business also performed strongly in H2, with the company explicitly attributing the outperformance to “strong financial performance in H2” and ongoing strategic delivery...
.wealthoracle.co.uk/featured-companies